Axiogenesis

engages in the development and commercialization of tissue-specific human cell types derived from induced pluripotent stem cells...
Read more
Axiogenesis Co-Founder & CEO: Heribert Bohlen

Co-Founder & CEO

Heribert Bohlen

CEO Approval Rating

72/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?

Axiogenesis Competitors

1DefiniGEN
2Forendo Pharma
3Axol
4Bit Bio
5Cellular Dynamics International, Inc.
6Cell Applications
7STEMCELL
8Lineage
9Pluriomics
10Arecor

Trending Companies